Predictive DNA-testing for Huntington's disease and reproductive decision making: a European collaborative study

Area of Science:

• Genetics
• Reproductive Health
• Medical Ethics

Background:

• Huntington's disease (HD) is a progressive neurodegenerative disorder.
• Predictive genetic testing for HD allows individuals to learn their mutation status before symptom onset.
• Reproductive choices are a significant concern for individuals at risk of transmitting HD.

Purpose of the Study:

• To evaluate the effect of predictive test results for Huntington's disease on subsequent reproductive behavior.
• To compare reproduction rates between carriers and non-carriers of the Huntington mutation.
• To analyze reproductive decisions in individuals who underwent predictive testing for family planning reasons.

Main Methods:

• A European collaborative study involving 180 HD carriers and 271 non-carriers who received predictive test results between 1993-1998.
• Data collection focused on subsequent pregnancies and reproductive choices.
• Follow-up intervals ranged from 3 to 7 years, with a subgroup analysis for those citing 'family planning' as a motive.

Main Results:

• Overall, 14% of carriers had subsequent pregnancies compared to 28% of non-carriers.
• In a subgroup motivated by family planning, 39% of carriers had pregnancies versus 69% of non-carriers.
• Prenatal diagnosis was utilized in about two-thirds of pregnancies among carriers.

Conclusions:

• Predictive testing for Huntington's disease has a clear impact on subsequent reproductive decisions.
• Individuals at risk of HD are less likely to reproduce after receiving a positive test result.
• Respect and support for reproductive choices are crucial for couples facing the risk of transmitting Huntington's disease.